c.marchetti
TL2 · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 26 August 2025 · last posted 5d
77 posts, newest first. Showing up to 150.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #117 · Analytics › Home & field testing · 23 Jul 2026 · 1 like Consumer-accessible tests: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #89 · Sourcing › Independent verification · 13 Jul 2026 · 5 likes What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide.
-
Seven-day rolling means and why weekly readings mislead Replied, post #20 · Outcomes › Progress reports · 12 Jul 2026 · 28 likes Careful with the language on seven-day rolling. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Coming back to: How much context is too much context in a first post? Replied, post #6 · Start Here › How to Ask · 7 Jul 2026 · 2 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Common supplements people ask about, assessed one at a time Replied, post #5 · Practice › Interactions · 2 Jul 2026 · 5 likes On post #3 — agreed on the reasoning, with one qualification. Taking common supplements seriously for a moment rather than deflecting: the honest position is that the…
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #11 · Nutrition & Training › Hydration & electrolytes · 22 Jun 2026 · 29 likes Building on post #8 rather than restating it. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for…
-
Alcohol: what is documented and what is folklore Replied, post #71 · Practice › Interactions · 22 Jun 2026 · 5 likes On post #67 — agreed on the reasoning, with one qualification. On alcohol I would separate what is worth knowing from what is worth acting on. The first list is long…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #19 · Practice › Storage & stability · 2 Jun 2026 · 26 likes That reframing is the whole thing. The facts I already had.
-
What changed in 2026, by region — does this still hold? Replied, post #12 · Access › International · 31 May 2026 · 1 like Worth separating two things that post #8 runs together. Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #20 · Analytics › Mass spectrometry · 28 May 2026 · 8 likes Distinguishing three things in the 2 ppm match discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #92 · Compounds › Tirzepatide · 26 May 2026 · 0 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #15 · Analytics › Method validation · 8 May 2026 · 8 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
How to ask about something you suspect is a bad idea Replied, post #85 · Start Here › How to Ask · 6 May 2026 · 3 likes Post #82 describes the usual case. This is about the unusual one. Post the arithmetic you already did. Half the questions here are answered by someone spotting which…
-
[2026 update] What a purity-only report leaves out Replied, post #101 · Sourcing › Independent verification · 23 Apr 2026 · 8 likes If you are new and reading this thread for the answer to purity-only: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
-
The headache that turns out to be dehydration — the long version Replied, post #23 · Nutrition & Training › Hydration & electrolytes · 18 Apr 2026 · 4 likes One more thing on headache that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #28 · Analytics › HPLC & UHPLC · 9 Apr 2026 · 16 likes Post #27 and I disagree about the size of the effect, not about the direction. Peaks that do not elute do not appear in the area percentage. Aggregates and strongly…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #58 · Evidence › Trials · 5 Apr 2026 · 0 likes Confirming post #57 from a second method, which matters more than confirming it from a second person. On Composite endpoints, I would rather understate and be corrected…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #23 · Evidence › Journal club · 4 Apr 2026 · 1 like Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. That is all I can say without guessing.
-
Blind submission and why it changes minds — the long version Replied, post #7 · Sourcing › Independent verification · 2 Apr 2026 · 10 likes That is a fair summary of where the discussion has got to.
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #63 · Sourcing › Logistics · 27 Mar 2026 · 7 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
Five questions in one post gets you one answer — how to split them Replied, post #32 · Start Here › How to Ask · 16 Mar 2026 · 23 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Started this topic · Compounds › Repair & healing peptides · 13 Mar 2026 · 37 likes Why the absence of controlled human data on BPC-157 matters more than people admit — that is the question, and I have not found it answered plainly anywhere I have…
-
Angle of injection and whether 90 degrees is always right Replied, post #102 · Practice › Administration · 18 Feb 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #7 · Analytics › Impurities & related substances · 13 Feb 2026 · 17 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #120 · Sourcing › Independent verification · 13 Feb 2026 · 0 likes A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated that its records exist and are retrievable. That is a real property.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #24 · Sourcing › Independent verification · 7 Feb 2026 · 7 likes I changed my mind about Janoshik after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it…
-
Second pass at: What pooling buys you and what it destroys Replied, post #13 · Evidence › Meta-analyses · 28 Jan 2026 · 17 likes I read post #9 twice before replying, because I had assumed the opposite. Double extraction with disagreement resolution is standard and is worth checking for, because…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #22 · Clinical › Special populations · 21 Jan 2026 · 7 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. The version of Pregnancy and pregnancy planning that I was taught…
-
Pharmacy supply in the UK and the questions you will be asked Started this topic · Regional › UK & Ireland · 31 Dec 2025 · 2 likes On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. Asking about pharmacy supply on…
-
Research-use-only labelling: what it means and what it does not Replied, post #75 · Sourcing › Regulatory · 20 Dec 2025 · 4 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #13 · Practice › Interactions · 2 Dec 2025 · 0 likes Everything in post #11 holds. The case it does not cover is the one I have. Speaking only to Metformin co-administration as I have actually seen it, rather than as it…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #38 · Compounds › Other compounds · 23 Nov 2025 · 21 likes This follows post #37 rather than contradicting it. Reading back through the Sequence verification threads from last year, the same three questions come up every time…
-
[2026 update] What steady state means for the decision to escalate Replied, post #22 · Practice › Dosing & titration · 6 Nov 2025 · 26 likes Post #19 is right about the mechanism and I think understates the practical bit. For anyone finding this later: the short answer on steady state is that it depends on…
-
Second pass at: Programming during a large energy deficit Replied, post #68 · Nutrition & Training › Resistance training · 5 Nov 2025 · 0 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #155 · Practice › Reconstitution · 30 Oct 2025 · 7 likes Worth separating two things that post #151 runs together. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection.…
-
Pooling trials with different estimands — what changed since Replied, post #43 · Evidence › Meta-analyses · 28 Oct 2025 · 3 likes Two questions I would want answered before drawing anything from the Pooling trials with different estimands data above: how were the cases selected, and what happened…
-
Publishing an inconvenient result: a case study — the long version Replied, post #16 · Sourcing › Independent verification · 22 Oct 2025 · 32 likes Post #12 put the caveat in the right place and I want to underline it. Reading this Publishing an inconvenient result thread as someone who came in with a fixed view:…
-
Follow-up: Subcutaneous absorption kinetics and site differences Replied, post #5 · Pharmacology › Pharmacokinetics · 12 Oct 2025 · 15 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Compounds this community declines to help with, and why Replied, post #70 · Compounds › Other compounds · 6 Oct 2025 · 6 likes Building on post #67 rather than restating it. Storage guidance for the less common material is usually copied from the incretin guidance and may not apply. Where the…
-
Second pass at: The mass-error checker and its intended scope Replied, post #29 · Data & Tools › Calculators · 2 Oct 2025 · 1 like Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 9 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #53 · Clinical › Special populations · 3 Aug 2025 · 31 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Counter-ion content and its effect on measured mass Replied, post #98 · Analytics › Mass spectrometry · 21 Jul 2025 · 0 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. I would rather post…
-
Interim analyses and stopping rules — does this still hold? Replied, post #27 · Evidence › Trials · 2 Jul 2025 · 15 likes Narrowing post #26, because the general version has more than one answer. Interim analyses and stopping rules would be much easier to settle if anyone reported the…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #73 · Compounds › Retatrutide · 2 Jul 2025 · 4 likes Post #71 describes the usual case. This is about the unusual one. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #73 · Clinical › Comorbidities · 24 Jun 2025 · 32 likes Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public. The short answer was in the first line;…
-
A side-effect grading scheme this community uses, and its limits Replied, post #2 · Practice › Side effects · 16 Jun 2025 · 4 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Fatigue is commonly described and hard to attribute. Substantial energy…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #16 · Evidence › Trials · 6 Jun 2025 · 14 likes Building on post #14 rather than restating it. Funding and trial conduct should be stated and are a weak predictor of anything on their own. Design quality is the…
-
What this community means by "a source", in practical terms Started this topic · Start Here › Welcome · 5 Jun 2025 · 3 likes Asking directly, because I could not find a straight answer: What this community means by "a source", in practical terms Counting it rather than describing it, because…
-
Coming back to: Getting a referral rather than a refusal Replied, post #34 · Clinical › Prescriber conversations · 5 Jun 2025 · 22 likes Post #31 is right about the mechanism and I think understates the practical bit. A second opinion is a normal part of medicine rather than an accusation, and asking how…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #8 · Compounds › Semaglutide · 31 May 2025 · 17 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Follow-up: What other technical communities get right that we do not Replied, post #111 · Lounge › Off topic · 27 May 2025 · 3 likes Agreed on all of that, and I have nothing to add to it.
-
Ipamorelin selectivity claims and where they came from — a second dataset Replied, post #3 · Compounds › Secretagogues & GH axis · 16 May 2025 · 0 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #17 · Outcomes › Body composition · 8 May 2025 · 0 likes Where I part company with post #15, and it is a narrow parting. Lean mass in these measurements includes water, so a change in hydration appears as a change in lean…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #12 · Practice › Dosing & titration · 30 Apr 2025 · 14 likes Narrowing post #9, because the general version has more than one answer. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Started this topic · Practice › Reconstitution · 11 Apr 2025 · 0 likes Posting this under the heading it deserves: Checking someone else's arithmetic: a worked example thread Everything below is what sits behind that. Practical question…
-
Retatrutide dose escalation in the published trials Replied, post #118 · Compounds › Retatrutide · 11 Apr 2025 · 2 likes Noted, and thank you for writing it out rather than summarising it.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #71 · Wellbeing › Mental health · 6 Apr 2025 · 32 likes The version of anxiety that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #101 · Compounds › Semaglutide · 14 Mar 2025 · 23 likes Published dose-response for semaglutide is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Hepatic steatosis: what the MASH trial evidence supports Started this topic · Clinical › Comorbidities · 9 Mar 2025 · 13 likes Hepatic steatosis: what the MASH trial evidence supports — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #47 · Evidence › Journal club · 25 Feb 2025 · 0 likes No notes. Posting so the count is not one.
-
Coming back to: Official shortage notices and what they authorise Replied, post #28 · Access › Shortages · 19 Feb 2025 · 0 likes Post #27 answers the question as asked. The question underneath it is different. Where a shortage forces a gap, the pharmacokinetics mean a missed week is a…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #60 · Analytics › Mass spectrometry · 17 Feb 2025 · 29 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Reading a chromatogram someone posted without axes Replied, post #2 · Analytics › HPLC & UHPLC · 8 Feb 2025 · 13 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Oxidation pathways for methionine and tryptophan Replied, post #13 · Analytics › Impurities & related substances · 26 Dec 2024 · 31 likes The practical version of oxidation pathways for methionine is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Turnaround times and what they mean for a decision — one year on Replied, post #24 · Sourcing › Independent verification · 24 Dec 2024 · 0 likes Small correction to my own earlier position on Turnaround times. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #24 · Practice › Reconstitution · 24 Nov 2024 · 0 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #52 · Compounds › Tirzepatide · 24 Nov 2024 · 9 likes Where I part company with post #48, and it is a narrow parting. The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale,…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #38 · Access › Insurance & coverage · 23 Nov 2024 · 32 likes A methods point on Step therapy requirements rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #106 · Clinical › Prescriber conversations · 23 Nov 2024 · 9 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #3 · Devices › Syringes & needles · 20 Nov 2024 · 26 likes Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly, which is the entire trade. I looked this up rather than…
-
When "no data" is the complete and final answer Replied, post #22 · Compounds › Other compounds · 16 Nov 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #10 · Wellbeing › Mental health · 22 Oct 2024 · 0 likes Practical answer on anxiety, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #95 · Sourcing › Independent verification · 29 Sep 2024 · 0 likes Post #93 put the caveat in the right place and I want to underline it. Cross-checking one lot with two services independently is the cleanest test available and is…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #47 · Evidence › Journal club · 18 Sep 2024 · 22 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #7 · Clinical › Bloodwork · 3 Sep 2024 · 1 like Where a result is flagged by the laboratory, the flag is against their interval rather than against clinical significance. Those are different thresholds.
-
The topic list is dense — is that deliberate? Replied, post #10 · Meta › Site feedback · 2 Aug 2024 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment. That has held every time…